Bone Marrow Cellularity at Day 14 Is the Most Important Predictive Factor for Response in Patients With AML Who Require Double ‐Induction Chemotherapy: Analysis From a Large, Single Institution Experience

This article is protected by copyright. All rights reserved.

Source: American Journal of Hematology - December 21, 2016 Category: Hematology Authors: Patrick T. Griffin, Rami S. Komrokji, Kendra Sweet, Najla H. Al Ali, Eric Padron, Timothy E. Kubal, Alan F. List, Jeffrey E. Lancet Tags: Research Article Source Type: research